Radiopharm Theranostics Limited American Depositary Shares (RADX) — Net Asset Quality Index
Radiopharm Theranostics Limited American Depositary Shares (RADX) has a Net Asset Quality Index of 56.2% as of December 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $92.45 Million minus total liabilities of $40.45 Million yields net assets of $52.00 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check RADX strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Radiopharm Theranostics Limited American Depositary Shares Net Asset Quality Index Over Time (2022–2025)
This chart shows how Radiopharm Theranostics Limited American Depositary Shares's Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of December 2024, the index stands at 56.2%, representing net assets of $52.00 Million against total assets of $92.45 Million USD. Also explore RADX asset base for the complete picture of this company's asset base.
Annual Net Asset Quality Index for Radiopharm Theranostics Limited American Depositary Shares (2022–2025)
The table below presents the year-by-year Net Asset Quality Index for Radiopharm Theranostics Limited American Depositary Shares from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Radiopharm Theranostics Limited American stock valuation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 49.6% | $42.87 Million | $86.48 Million | $43.61 Million | ▲ +11.6 pp |
| 2024 | 38.0% | $27.35 Million | $72.04 Million | $44.68 Million | ▼ -22.8 pp |
| 2023 | 60.8% | $45.58 Million | $74.95 Million | $29.37 Million | ▼ -14.7 pp |
| 2022 | 75.5% | $62.96 Million | $83.38 Million | $20.42 Million | — |